2018 MG Conference - New Treatment Pathways in Myasthenia Gravis
New Treatment Pathways in Myasthenia Gravis, presented at the 2018 National MG Conference in Kansas City, MO, hosted by the MGFA. Speakers: James Howard, MD, Distinguished Professor of Neuromuscular Disease; Professor of Neurology & Medicine, Chief, Nueromuscular Disorders Section, UNC School of Medicine Linda Kusner, PhD, MGFA Medical / Scientific Advisory Board Chair Associate Research Professor, George Washington University For more research news, check out our website: http://myasthenia.org
▶︎
MDUK Muscles Matter 2021: myasthenia gravis seminar
▶︎
First IVIG Infusion Experience | Myasthenia Gravis
▶︎
2018 MG Conference: Remission – What, Why, How 14
▶︎
Advances in the Treatment of Myasthenia Gravis
▶︎
Ensuring equitable access to targeted therapies: the regulatory perspective
▶︎
Myasthenia Gravis | Symptoms and Treatment | Part 1🩺
▶︎
Sheryl and Myasthenia Gravis: How I Cope!
▶︎
2018 MGFA Conference Keynote : Andrew E. Kaufman, Best-selling Author
▶︎
Jon Stewart on Trump's "Meritocracy" & Desi Lydic on MAGA Moving Iran Goalposts | The Daily Show
▶︎
Myasthenia Gravis Therapy in 2022 New Data and New Treatments
▶︎
New and Emerging Treatments for Myasthenia Gravis
▶︎
Holly's story: My experience with MG treatments
▶︎
2022 MGFA National Patient Conference: Seronegative: How to Navigate this Diagnosis
▶︎
#LetstalkNMD Webinar - FcRn Inhibitors and Novel Options for Myasthenia Gravis
▶︎
2018 MG Conference - Crisis/ Emergency Management
▶︎
15 Years to Diagnosis of Myasthenia Gravis • PHANIE TALKS
▶︎
2018 MG Conference - Biomarkers in MG Research
▶︎
Emerging Therapies for Myasthenia Gravis
▶︎
Myasthenia Gravis - My Story
▶︎